Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Sends Clear Message: Hearing Aids Are Restricted Devices

This article was originally published in The Gray Sheet

Executive Summary

FDA believes granting over-the-counter status for hearing aids would be detrimental to public health

You may also be interested in...

Hearing Aids Without A Prescription? Citizen Petitions Seek OTC Status

FDA should allow hearing aids to be sold over the counter to promote wider access to the devices, two August citizen petitions assert

Crystal Care violation of hearing aid dispensing rules cited in FDA warning letter.

CRYSTAL CARE'S HEARING AID NOISE REDUCTION CLAIMS IN INFOMERCIAL violate FDA's premarket requirements, the agency says in a Dec. 30 letter to the Lutz, Florida-based company. Citing Crystal Care International, Inc. for making unapproved claims for its Crystal Ear 100 hearing aid, FDA says the device "has not been cleared for the claim of eliminating background noise or to improve hearing in noisy environments."

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts